Solara Active Pharma Sciences Limited — Board Meeting, 24-01-2025: Outcome of Board Meeting

The Board of Directors of Solara Active Pharma Sciences has announced a board meeting to discuss the unaudited financial results for the quarter and nine months ended December 31, 2024. The agenda includes a proposal to explore the demerger of the CRAMS and Polymers business into an independent listed entity, which has received in-principle approval from the Board. This move aims to enhance focus on each business segment and will involve preparatory steps such as appointing valuers and drafting a scheme of arrangement. The company will provide further updates as necessary.